TY - JOUR
T1 - Hot spot imaging in cardiovascular diseases
T2 - an information statement from SNMMI, ASNC, and EANM
AU - Sperry, Brett W.
AU - Bateman, Timothy M.
AU - Akin, Esma A.
AU - Bravo, Paco E.
AU - Chen, Wengen
AU - Dilsizian, Vasken
AU - Hyafil, Fabien
AU - Khor, Yiu Ming
AU - Miller, Robert J. H.
AU - Slart, Riemer H. J. A.
AU - Slomka, Piotr
AU - Verberne, Hein
AU - Miller, Edward J.
AU - Liu, Chi
N1 - Funding Information: Dr. Sperry has received research support and speaking honoraria from Pfizer, and consults for BridgeBio and Alnylam. Dr. Robert Miller receives consulting fees and research support from Pfizer. Drs. Akin, Bravo, Chen, Dilsizian, Khor, Slart, Verberne have no disclosures to report. Dr. Bateman has research grants from Bracco, GE Healthcare, and Spectrum Dynamics, consults for GE Healthcare, receives royalties from SPECT and PET software products, and has equity interest in Cardiovascular Imaging Technologies. Dr. Miller has grant support from Eidos, Pfizer, and Alnylam, and consults for Eidos, Pfizer, and Roivant. Dr. Hyafil has consultancy and speaking fees from Blue Earth Diagnostics, Bracco Imaging, Curium, GE Healthcare, Naogen, and Pfizer. Dr. Slomka has research grant support from Siemens and the NIH (R01HL089765R01HL135557, R35HL161195) and software royalties from Cedars-Sinai. Dr. Liu reports research contract with Siemens Medical Solutions. Publisher Copyright: © 2022, American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging.
PY - 2022
Y1 - 2022
N2 - This information statement from the Society of Nuclear Medicine and Molecular Imaging, American Society of Nuclear Cardiology, and European Association of Nuclear Medicine describes the performance, interpretation, and reporting of hot spot imaging in nuclear cardiology. The field of nuclear cardiology has historically focused on cold spot imaging for the interpretation of myocardial ischemia and infarction. Hot spot imaging has been an important part of nuclear medicine, particularly for oncology or infection indications, and the use of hot spot imaging in nuclear cardiology continues to expand. This document focuses on image acquisition and processing, methods of quantification, indications, protocols, and reporting of hot spot imaging. Indications discussed include myocardial viability, myocardial inflammation, device or valve infection, large vessel vasculitis, valve calcification and vulnerable plaques, and cardiac amyloidosis. This document contextualizes the foundations of image quantification and highlights reporting in each indication for the cardiac nuclear imager.
AB - This information statement from the Society of Nuclear Medicine and Molecular Imaging, American Society of Nuclear Cardiology, and European Association of Nuclear Medicine describes the performance, interpretation, and reporting of hot spot imaging in nuclear cardiology. The field of nuclear cardiology has historically focused on cold spot imaging for the interpretation of myocardial ischemia and infarction. Hot spot imaging has been an important part of nuclear medicine, particularly for oncology or infection indications, and the use of hot spot imaging in nuclear cardiology continues to expand. This document focuses on image acquisition and processing, methods of quantification, indications, protocols, and reporting of hot spot imaging. Indications discussed include myocardial viability, myocardial inflammation, device or valve infection, large vessel vasculitis, valve calcification and vulnerable plaques, and cardiac amyloidosis. This document contextualizes the foundations of image quantification and highlights reporting in each indication for the cardiac nuclear imager.
KW - Basic science
KW - diseases/processes
KW - modalities
UR - http://www.scopus.com/inward/record.url?scp=85134617577&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s12350-022-02985-8
DO - https://doi.org/10.1007/s12350-022-02985-8
M3 - Article
C2 - 35864433
SN - 1071-3581
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
ER -